CTLA4 and nonpapillary renal cell carcinoma: Understanding the epigenetic regulation of CTLA4 in ccRCC is of major interest, as it might be promising as a predictive biomarker to enable a more rational therapeutic decision in favor or against ICB+ICB in patients with ccRCC in the age of individualized therapy.